Idiopathic pulmonary fibrosis

por Meltzer, Eric B, Noble, Paul W
Publicado 2008

Disruption of respiratory epithelial basement membrane in COVID-19 patients

por Liu, Xue, Fang, Yinshan, Noble, Paul W., Que, Jianwen, Jiang, Dianhua
Publicado 2021

Alveolar Epithelial Type II Cells as Drivers of Lung Fibrosis in Idiopathic Pulmonary Fibrosis

por Parimon, Tanyalak, Yao, Changfu, Stripp, Barry R, Noble, Paul W, Chen, Peter
Publicado 2020

Abnormal respiratory progenitors in fibrotic lung injury

por Xie, Ting, Lynn, Heather, Parks, William C., Stripp, Barry, Chen, Peter, Jiang, Dianhua, Noble, Paul W.
Publicado 2022

Multiple Fibroblast Subtypes Contribute to Matrix Deposition in Pulmonary Fibrosis

por Liu, Xue, Dai, Kristy, Zhang, Xuexi, Huang, Guanling, Lynn, Heather, Rabata, Anas, Liang, Jiurong, Noble, Paul W., Jiang, Dianhua
Publicado 2023

Severe lung fibrosis requires an invasive fibroblast phenotype regulated by hyaluronan and CD44

por Li, Yuejuan, Jiang, Dianhua, Liang, Jiurong, Meltzer, Eric B., Gray, Alice, Miura, Riu, Wogensen, Lise, Yamaguchi, Yu, Noble, Paul W.
Publicado 2011

Correction to: Cardiovascular Risks, Bleeding Risks, and Clinical Events from 3 Phase III Trials of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis

por Glassberg, Marilyn K., Nathan, Steven D., Lin, Chin-Yu, Morgenthien, Elizabeth A., Stauffer, John L., Chou, Willis, Noble, Paul W.
Publicado 2019

Cardiovascular Risks, Bleeding Risks, and Clinical Events from 3 Phase III Trials of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis

por Glassberg, Marilyn K., Nathan, Steven D., Lin, Chin-Yu, Morgenthien, Elizabeth A., Stauffer, John L., Chou, Willis, Noble, Paul W.
Publicado 2019

CC-90001, a c-Jun N-terminal kinase (JNK) inhibitor, in patients with pulmonary fibrosis: design of a phase 2, randomised, placebo-controlled trial

por Popmihajlov, Zoran, Sutherland, Donna J, Horan, Gerald S, Ghosh, Atalanta, Lynch, David A, Noble, Paul W, Richeldi, Luca, Reiss, Theodore F, Greenberg, Steven
Publicado 2022

Effect of pirfenidone in patients with more advanced idiopathic pulmonary fibrosis

por Costabel, Ulrich, Albera, Carlo, Glassberg, Marilyn K., Lancaster, Lisa H., Wuyts, Wim A., Petzinger, Ute, Gilberg, Frank, Kirchgaessler, Klaus-Uwe, Noble, Paul W.
Publicado 2019

Lung Transplantation for Covid-19–Related Respiratory Failure in the United States

por Roach, Amy, Chikwe, Joanna, Catarino, Pedro, Rampolla, Reinaldo, Noble, Paul W., Megna, Dominick, Chen, Qiudong, Emerson, Dominic, Egorova, Natalia, Keshavjee, Shaf, Kirklin, James K.
Publicado 2022

Comprehensive assessment of the long-term safety of pirfenidone in patients with idiopathic pulmonary fibrosis

por Valeyre, Dominique, Albera, Carlo, Bradford, Williamson Z, Costabel, Ulrich, King, Talmadge E, Leff, Jonathan A, Noble, Paul W, Sahn, Steven A, du Bois, Roland M
Publicado 2014

Methylation-mediated BMPER expression in fibroblast activation in vitro and lung fibrosis in mice in vivo

por Huan, Caijuan, Yang, Ting, Liang, Jiurong, Xie, Ting, Cheng, Luis, Liu, Ningshan, Kurkciyan, Adrianne, Monterrosa Mena, Jessica, Wang, Chen, Dai, Huaping, Noble, Paul W., Jiang, Dianhua
Publicado 2015

Clinical Characteristics and Outcomes Among Adults Hospitalized with Laboratory-Confirmed SARS-CoV-2 Infection During Periods of B.1.617.2 (Delta) and B.1.1.529 (Omicron) Variant P...

por Modes, Matthew E, Directo, Michael P., Melgar, Michael, Johnson, Lily R., Yang, Haoshu, Chaudhary, Priya, Bartolini, Susan, Kho, Norling, Noble, Paul W., Isonaka, Sharon, Chen, Peter
Publicado 2022

Familial and sporadic idiopathic pulmonary fibrosis: making the diagnosis from peripheral blood

por Meltzer, Eric B, Barry, William T, Yang, Ivana V, Brown, Kevin K, Schwarz, Marvin I, Patel, Hamish, Ashley, Allison, Noble, Paul W, Schwartz, David A, Steele, Mark P
Publicado 2014

Dose modification and dose intensity during treatment with pirfenidone: analysis of pooled data from three multinational phase III trials

por Nathan, Steven D, Lancaster, Lisa H, Albera, Carlo, Glassberg, Marilyn K, Swigris, Jeffrey J, Gilberg, Frank, Kirchgaessler, Klaus-Uwe, Limb, Susan L, Petzinger, Ute, Noble, Paul W
Publicado 2018

Bayesian probit regression model for the diagnosis of pulmonary fibrosis: proof-of-principle

por Meltzer, Eric B, Barry, William T, D'Amico, Thomas A, Davis, Robert D, Lin, Shu S, Onaitis, Mark W, Morrison, Lake D, Sporn, Thomas A, Steele, Mark P, Noble, Paul W
Publicado 2011

Pirfenidone Treatment in Individuals with Idiopathic Pulmonary Fibrosis: Impact of Timing of Treatment Initiation

por Maher, Toby M., Lancaster, Lisa H., Jouneau, Stéphane, Morrison, Lake, Lederer, David J., Molina-Molina, Maria, Bendstrup, Elisabeth, Kirchgaessler, Klaus-Uwe, Gilberg, Frank, Axmann, Judit, Petzinger, Ute, Noble, Paul W.
Publicado 2019

Reciprocal interactions between alveolar progenitor dysfunction and aging promote lung fibrosis

por Liang, Jiurong, Huang, Guanling, Liu, Xue, Liu, Ningshan, Taghavifar, Forough, Dai, Kristy, Yao, Changfu, Deng, Nan, Wang, Yizhou, Chen, Peter, Hogaboam, Cory, Stripp, Barry R, Parks, William C, Noble, Paul W, Jiang, Dianhua
Publicado 2023

Early Growth Response Gene 1–mediated Apoptosis Is Essential for Transforming Growth Factor β(1)–induced Pulmonary Fibrosis

por Lee, Chun Geun, Cho, Soo Jung, Kang, Min Jong, Chapoval, Svetlana P., Lee, Patty J., Noble, Paul W., Yehualaeshet, Teshome, Lu, Binfeng, Flavell, Richard A., Milbrandt, Jeffrey, Homer, Robert J., Elias, Jack A.
Publicado 2004